Table 2.

Semiquantitative analysis of antibody response to angiogenic cytokines in vaccinated patients with AML early after allogeneic HSCT

Patient numberL1DEL-1AnglAng2HGFPDGFVEGF-APGRN
1
4++
8+
9+++++++++++++
11+++++++
12++++++++
14+++++
16
17
18
19
20+++
21
23+++++++++++++
26
27+++++++++++++

NOTE: +, two and one half to 5-fold increases; ++, 5- to 7-fold increases; +++, 8- and greater fold increases